Dr. Jill Felder, MD (she/her) is an Endocrinologist, Internist in Steubenville, OH with over 16 years of experience. What is your opinion of Dr. Jill Felder, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jill Felder, MD has received over $30,159 which includes payments from the following companies:
$19,725.71 from sanofi-aventis U.S. LLC
$1,673.30 from Novo Nordisk Inc
$1,430.91 from LILLY USA, LLC
$1,102.23 from AstraZeneca Pharmaceuticals LP
$895.46 from Boehringer Ingelheim Pharmaceuticals, Inc.
$675.42 from Merck Sharp & Dohme Corporation
$664.16 from Janssen Pharmaceuticals, Inc
$493.77 from Amgen Inc.
$437.42 from GlaxoSmithKline, LLC.
$344.53 from Valeritas, Inc.
$327.41 from Corcept Therapeutics
$298.87 from INSULET CORPORATION
$245.04 from Amarin Pharma Inc.
$199.87 from AbbVie, Inc.
$194.82 from Takeda Pharmaceuticals America, Inc.
$192.48 from Roche Diabetes Care, Inc.
$156.96 from Abbott Laboratories
$147.25 from Roche Diagnostics Corporation
$135.27 from Shire North American Group Inc
$81.36 from Zealand Pharma US, Inc.
Payments received by Dr. Jill Felder, MD were from the following categories:
$15,605.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!